{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T03:09:44Z","timestamp":1769569784952,"version":"3.49.0"},"reference-count":22,"publisher":"BMJ","issue":"1","license":[{"start":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T00:00:00Z","timestamp":1769472000000},"content-version":"unspecified","delay-in-days":26,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100009708","name":"Novo Nordisk Fonden","doi-asserted-by":"publisher","award":["NNF20OC0060657"],"award-info":[{"award-number":["NNF20OC0060657"]}],"id":[{"id":"10.13039\/501100009708","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open Resp Res"],"accepted":{"date-parts":[[2025,12,19]]},"published-print":{"date-parts":[[2026,1]]},"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Vitamin K, through its role in the vitamin K-dependent activation of matrix-GLA-protein, has been suggested to have a lung-protective effect, though the mechanism is unknown. Chronic obstructive pulmonary disease (COPD) patients treated with vitamin K antagonists (VKAs) may lose this protection, thereby increasing their risk of an acute exacerbation of COPD (AE-COPD) and death. We examined this hypothesis in a nationwide cohort of COPD patients treated with VKA. COPD patients treated with direct oral anticoagulant (DOAC) served as controls.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To assess the association between VKA treatment and the 1-year risk of AE-COPD-related hospitalisation and all-cause mortality in patients with COPD and atrial fibrillation or flutter.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This nationwide, observational, register-based cohort study applied Cox proportional hazard regression models, adjusting for established confounders. HRs with 95% CIs were reported. Sensitivity analyses included complete-case analysis and inverse probability of treatment weighting (IPTW).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>A total of 7091 COPD patients were included, of whom 3455 (48.7%) received VKA treatment. A total of 1955 patients reached the endpoint, including 820 in the VKA-treated group. In the primary analysis, VKA treatment was associated with a lower risk of AE-COPD hospitalisation or death (adjusted HR of 0.87 (95% CI 0.78 to 0.98), p=0.024). The association remained in the sensitivity analyses but lost statistical significance. Complete-case analysis: adjusted HR of 0.88 (CI 0.76 to 1.01), p=0.079. IPTW analysis: HR of 0.85 (CI 0.72 to 1.01), p=0.070.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Interpretation<\/jats:title>\n                    <jats:p>VKA treatment was associated with a reduction in risk of AE-COPD hospitalisation and mortality compared to DOAC. Sensitivity analysis was consistent with the main analysis; however, it did not reach statistical significance.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjresp-2025-003814","type":"journal-article","created":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T13:10:28Z","timestamp":1769519428000},"page":"e003814","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":0,"title":["COPD and vitamin K antagonism: a cohort study of 1-year all-cause mortality and risk of hospitalisation due to a severe exacerbation"],"prefix":"10.1136","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-2137-8412","authenticated-orcid":false,"given":"B\u00e5rd-Emil Vang Vang","family":"Gundersen","sequence":"first","affiliation":[{"name":"Copenhagen Respiratory Research, Gentofte Hospital, Hellerup, Denmark"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna Kubel","family":"Vognsen","sequence":"additional","affiliation":[{"name":"Copenhagen University Hospital Gentofte, Hellerup, Denmark"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Josefin","family":"Ekl\u00f6f","sequence":"additional","affiliation":[{"name":"Section of Respiratory Medicine, Department of Medicine, Gentofte University Hospital, Hellerup, Denmark"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pradeesh","family":"Sivapalan","sequence":"additional","affiliation":[{"name":"Section of Respiratory Medicine, Department of Medicine, Herlev Hospital, Herlev, Denmark"},{"name":"University of Copenhagen Faculty of Health and Medical Sciences, Copenhagen, Denmark"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Allan","family":"Linneberg","sequence":"additional","affiliation":[{"name":"University of Copenhagen Faculty of Health and Medical Sciences, Copenhagen, Denmark"},{"name":"Frederiksberg University Hospital Center for Clinical Research and Prevention, Frederiksberg, Denmark"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tor","family":"Biering-S\u00f8rensen","sequence":"additional","affiliation":[{"name":"University of Copenhagen Faculty of Health and Medical Sciences, Copenhagen, Denmark"},{"name":"Department of Cardiology, Herlev and Gentofte Hospital, University of Copenhagen, Hellerup, Denmark"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jens-Ulrik St\u00e6hr","family":"Jensen","sequence":"additional","affiliation":[{"name":"Section of Respiratory Medicine, Department of Medicine, Herlev and Gentofte Hospital, University of Copenhagen, Hellerup, Denmark"},{"name":"Department of Clinical Medicine, University of Copenhagen Faculty of Health and Medical Sciences, Copenhagen, Denmark"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2026,1,27]]},"reference":[{"key":"2026012705101184000_13.1.e003814.1","doi-asserted-by":"publisher","DOI":"10.3402\/fnr.v56i0.18891"},{"key":"2026012705101184000_13.1.e003814.2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2009-09-201616"},{"key":"2026012705101184000_13.1.e003814.3","doi-asserted-by":"crossref","DOI":"10.3390\/nu12010138","article-title":"Vitamin K as a Diet Supplement with Impact in Human Health: Current Evidence in Age-Related Diseases","volume":"12","author":"Simes","year":"2020","journal-title":"Nutrients"},{"key":"2026012705101184000_13.1.e003814.4","doi-asserted-by":"crossref","DOI":"10.3390\/jcm12041261","article-title":"The Pleiotropic Role of Vitamin K in Multimorbidity of Chronic Obstructive Pulmonary Disease","volume":"12","author":"Piscaer","year":"2023","journal-title":"J Clin Med"},{"key":"2026012705101184000_13.1.e003814.5","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.mehy.2017.07.029","article-title":"Vitamin K deficit and elastolysis theory in pulmonary elasto-degenerative diseases","volume":"108","author":"Janssen","year":"2017","journal-title":"Med Hypotheses"},{"key":"2026012705101184000_13.1.e003814.6","doi-asserted-by":"crossref","DOI":"10.3390\/jcm8081116","article-title":"Low Vitamin K Status Is Associated with Increased Elastin Degradation in Chronic Obstructive Pulmonary Disease","volume":"8","author":"Piscaer","year":"2019","journal-title":"J Clin Med"},{"key":"2026012705101184000_13.1.e003814.7","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.01824-2015"},{"key":"2026012705101184000_13.1.e003814.8","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00239-2023","article-title":"Global Initiative for Chronic Obstructive Lung Disease 2023 Report: GOLD Executive Summary","volume":"61","author":"Agust\u00ed","year":"2023","journal-title":"Eur Respir J"},{"key":"2026012705101184000_13.1.e003814.9","doi-asserted-by":"publisher","DOI":"10.1136\/thx.2005.041830"},{"key":"2026012705101184000_13.1.e003814.10","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1093\/eurheartj\/ehaa822","article-title":"Chronic obstructive pulmonary disease and atrial fibrillation: an interdisciplinary perspective","volume":"42","author":"Simons","year":"2021","journal-title":"Eur Heart J"},{"key":"2026012705101184000_13.1.e003814.11","doi-asserted-by":"crossref","first-page":"871","DOI":"10.2147\/COPD.S49621","article-title":"Epidemiology and clinical impact of major comorbidities in patients with COPD","volume":"9","author":"Smith","year":"2014","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"2026012705101184000_13.1.e003814.12","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.ijcard.2018.10.075","article-title":"Why is chronic obstructive pulmonary disease linked to atrial fibrillation? A systematic overview of the underlying mechanisms","volume":"276","author":"Matarese","year":"2019","journal-title":"Int J Cardiol"},{"key":"2026012705101184000_13.1.e003814.13","doi-asserted-by":"publisher","DOI":"10.1016\/S0895-4356(02)00585-1"},{"key":"2026012705101184000_13.1.e003814.14","doi-asserted-by":"publisher","DOI":"10.1093\/ckj\/sfab158"},{"key":"2026012705101184000_13.1.e003814.15","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/s40471-015-0053-5","article-title":"The active comparator, new user study design in pharmacoepidemiology: historical foundations and contemporary application","volume":"2","author":"Lund","year":"2015","journal-title":"Curr Epidemiol Rep"},{"key":"2026012705101184000_13.1.e003814.16","doi-asserted-by":"publisher","DOI":"10.1136\/heartjnl-2017-312735"},{"key":"2026012705101184000_13.1.e003814.17","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehab453"},{"key":"2026012705101184000_13.1.e003814.18","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.ijcard.2015.09.062","article-title":"Chronic obstructive pulmonary disease in patients with atrial fibrillation: Insights from the ARISTOTLE trial","volume":"202","author":"Durheim","year":"2016","journal-title":"Int J Cardiol"},{"key":"2026012705101184000_13.1.e003814.19","doi-asserted-by":"crossref","first-page":"371","DOI":"10.2147\/COPD.S174443","article-title":"A prospective study of the clinical outcomes and prognosis associated with comorbid COPD in the atrial fibrillation population","volume":"14","author":"Rodr\u00edguez-Ma\u00f1ero","year":"2019","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"2026012705101184000_13.1.e003814.20","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2022.987652","article-title":"Effects of oral anticoagulant therapy in patients with pulmonary diseases","volume":"9","author":"Lai","year":"2022","journal-title":"Front Cardiovasc Med"},{"key":"2026012705101184000_13.1.e003814.21","doi-asserted-by":"crossref","first-page":"3429","DOI":"10.2147\/COPD.S340129","article-title":"COPD and Anticoagulation Therapy: Time for a New Approach?","volume":"16","author":"Petris","year":"2021","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"2026012705101184000_13.1.e003814.22","doi-asserted-by":"crossref","first-page":"368504221104331","DOI":"10.1177\/00368504221104331","article-title":"Association between anticoagulant therapy, exacerbations and mortality in a Danish cohort of patients with Chronic Obstructive Pulmonary Disease","volume":"105","author":"Kristensen","year":"2022","journal-title":"Sci Prog"}],"container-title":["BMJ Open Respiratory Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjresp-2025-003814","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T13:10:30Z","timestamp":1769519430000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopenrespres.bmj.com\/lookup\/doi\/10.1136\/bmjresp-2025-003814"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":22,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,1,27]]},"published-print":{"date-parts":[[2026,1]]}},"alternative-id":["10.1136\/bmjresp-2025-003814"],"URL":"https:\/\/doi.org\/10.1136\/bmjresp-2025-003814","relation":{},"ISSN":["2052-4439"],"issn-type":[{"value":"2052-4439","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1]]}}}